Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-29

B cells, splenic marginal zone, and complement -as opsonin and inflammatory mediator- in the immunopathogenesis of virally induced Type 1 Diabetes

Obiettivo

Approximately 150 million people are affected with diabetes mellitus worldwide. One form of diabetes, Type I diabetes, is an autoimmune disease that accounts for about 10% of all cases. It is mediated by T cells of the immune system that turn against the host (autoreactivity), and specifically destruct insulin-producing beta-cells of the pancreas. The resulting lack of insulin leads to chronic elevated blood sugar, and ultimately contributes to blindness, amputation, renal disease, and premature death.

Both genetic and environmental factors play a role in the development of Type I diabetes. Two widely used rodent models emulate aspects of human disease: while the NOD mouse strain is genetically susceptible and develops disease spontaneously, the RIP-LCMV transgenic mouse model requires an external stimulus, i.e. viral infection, to develop diabetes. This grant application contains a proposal to pursue clues from both literature and preliminary experiments that certain immunological factors (i.e. complement, B c ells, the marginal zone), normally associated with the NOD system, might also influence virally induced diabetes development. Defining shared immunological aspects between the two models could help further clarify the immunopathogenicity of human Type I diabetes.

Campo scientifico (EuroSciVoc)

Parole chiave

Argomento(i)

Invito a presentare proposte

FP6-2005-MOBILITY-5
Vedi altri progetti per questo bando

Meccanismo di finanziamento

EIF - Marie Curie actions-Intra-European Fellowships

Coordinatore

TECHNISCHE UNIVERSITAET MUENCHEN
Contributo UE
Nessun dato
Costo totale
Nessun dato